Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Aaronson

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Health and Quality of Life Outcomes|May 7, 2016
Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT)Eva-Maria Gamper, Morten Aa Petersen, Neil Aaronson, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2016
The use of EORTC measures in daily clinical practice-A synopsis of a newly developed manualLisa M Wintner, Monika Sztankay, Neil Aaronson, et al.
Familial Cancer|July 31, 2009
Attitude towards pre-implantation genetic diagnosis for hereditary cancerChantal Lammens, Eveline Bleiker, Neil Aaronson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2007
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networksDeborah Watkins Bruner, Charlene J Bryan, Neil Aaronson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic MalignanciesFabio Efficace, Francesco Cottone, Kathrin Sommer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 26, 2021
Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I-IIIQuirien Oort, Linda Dirven, Sietske A M Sikkes, et al.
Neuro-Oncology Practice|July 20, 2022
Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?Quirien Oort, Linda Dirven, Sietske A M Sikkes, et al.
Neuro-Oncology|April 11, 2022
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival periodMarijke B Coomans, Linda Dirven, Neil Aaronson, et al.
Lung Cancer (Amsterdam, Netherlands)|October 16, 2010
Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancerAd A Kaptein, Kazue Yamaoka, Lucia Snoei, et al.
British Journal of Cancer|January 5, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Health and Quality of Life Outcomes|May 7, 2016
Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT)Eva-Maria Gamper, Morten Aa Petersen, Neil Aaronson, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2016
The use of EORTC measures in daily clinical practice-A synopsis of a newly developed manualLisa M Wintner, Monika Sztankay, Neil Aaronson, et al.
Familial Cancer|July 31, 2009
Attitude towards pre-implantation genetic diagnosis for hereditary cancerChantal Lammens, Eveline Bleiker, Neil Aaronson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2007
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networksDeborah Watkins Bruner, Charlene J Bryan, Neil Aaronson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic MalignanciesFabio Efficace, Francesco Cottone, Kathrin Sommer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 26, 2021
Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I-IIIQuirien Oort, Linda Dirven, Sietske A M Sikkes, et al.
Neuro-Oncology Practice|July 20, 2022
Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?Quirien Oort, Linda Dirven, Sietske A M Sikkes, et al.
Neuro-Oncology|April 11, 2022
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival periodMarijke B Coomans, Linda Dirven, Neil Aaronson, et al.
Lung Cancer (Amsterdam, Netherlands)|October 16, 2010
Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancerAd A Kaptein, Kazue Yamaoka, Lucia Snoei, et al.
British Journal of Cancer|January 5, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.
Pageof 4